Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Optic Neuritis | 15 | 2024 | 175 | 8.090 |
Why?
|
Papilledema | 6 | 2023 | 130 | 2.570 |
Why?
|
Neuromyelitis Optica | 5 | 2023 | 266 | 2.560 |
Why?
|
Orbital Myositis | 3 | 2020 | 25 | 2.000 |
Why?
|
Optic Nerve Diseases | 5 | 2023 | 342 | 1.650 |
Why?
|
Lyme Neuroborreliosis | 2 | 2024 | 50 | 1.610 |
Why?
|
Susac Syndrome | 2 | 2023 | 22 | 1.580 |
Why?
|
Pseudotumor Cerebri | 3 | 2022 | 107 | 1.470 |
Why?
|
Vision Disorders | 8 | 2023 | 1093 | 1.370 |
Why?
|
Cluster Headache | 2 | 2020 | 54 | 1.320 |
Why?
|
Meningitis | 3 | 2021 | 219 | 1.320 |
Why?
|
Vasculitis | 2 | 2023 | 524 | 1.180 |
Why?
|
Aquaporin 4 | 4 | 2022 | 161 | 1.080 |
Why?
|
Neurology | 2 | 2024 | 786 | 0.930 |
Why?
|
Optic Nerve | 6 | 2022 | 571 | 0.930 |
Why?
|
Cranial Nerve Diseases | 1 | 2024 | 111 | 0.870 |
Why?
|
Visual Fields | 2 | 2020 | 1067 | 0.860 |
Why?
|
Autoantibodies | 6 | 2023 | 2126 | 0.850 |
Why?
|
Dyskinesias | 1 | 2023 | 79 | 0.850 |
Why?
|
Chickenpox | 1 | 2023 | 96 | 0.830 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 7 | 0.820 |
Why?
|
Retinal Artery Occlusion | 1 | 2023 | 83 | 0.810 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 21 | 0.780 |
Why?
|
Confusion | 1 | 2023 | 278 | 0.760 |
Why?
|
Headache Disorders | 1 | 2024 | 152 | 0.750 |
Why?
|
Intracranial Pressure | 2 | 2021 | 325 | 0.750 |
Why?
|
Nelson Syndrome | 1 | 2021 | 20 | 0.750 |
Why?
|
Leukoencephalopathies | 1 | 2024 | 260 | 0.740 |
Why?
|
Eye Hemorrhage | 1 | 2020 | 19 | 0.730 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 50 | 0.710 |
Why?
|
Abducens Nerve Diseases | 1 | 2021 | 44 | 0.710 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 63 | 0.710 |
Why?
|
Cranial Fossa, Posterior | 1 | 2021 | 134 | 0.700 |
Why?
|
Blepharoptosis | 1 | 2021 | 145 | 0.690 |
Why?
|
PrPSc Proteins | 1 | 2019 | 28 | 0.680 |
Why?
|
Retinoids | 1 | 2020 | 99 | 0.680 |
Why?
|
Facial Paralysis | 1 | 2024 | 346 | 0.670 |
Why?
|
Blepharospasm | 1 | 2019 | 34 | 0.670 |
Why?
|
Paresis | 1 | 2021 | 177 | 0.660 |
Why?
|
Herpes Zoster | 1 | 2022 | 252 | 0.660 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2019 | 56 | 0.650 |
Why?
|
Autoimmune Diseases | 3 | 2021 | 2257 | 0.650 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2021 | 892 | 0.640 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2019 | 92 | 0.640 |
Why?
|
Vascular Neoplasms | 1 | 2020 | 167 | 0.620 |
Why?
|
Orbital Pseudotumor | 1 | 2018 | 42 | 0.620 |
Why?
|
Spinocerebellar Ataxias | 1 | 2019 | 108 | 0.610 |
Why?
|
Encephalitis | 1 | 2022 | 441 | 0.600 |
Why?
|
Ocular Motility Disorders | 1 | 2019 | 144 | 0.600 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.600 |
Why?
|
Lyme Disease | 1 | 2024 | 631 | 0.590 |
Why?
|
Craniopharyngioma | 1 | 2020 | 279 | 0.580 |
Why?
|
Blindness | 3 | 2021 | 587 | 0.580 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 281 | 0.570 |
Why?
|
Ataxia | 1 | 2019 | 307 | 0.570 |
Why?
|
Skull Base | 1 | 2019 | 294 | 0.550 |
Why?
|
Optic Disk | 2 | 2021 | 422 | 0.550 |
Why?
|
Multiple Sclerosis | 2 | 2023 | 3247 | 0.550 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2019 | 417 | 0.510 |
Why?
|
Magnetic Resonance Imaging | 13 | 2023 | 36849 | 0.480 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3118 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.460 |
Why?
|
Eye Diseases | 2 | 2021 | 657 | 0.430 |
Why?
|
Retina | 2 | 2023 | 2661 | 0.420 |
Why?
|
Pandemics | 4 | 2021 | 8750 | 0.410 |
Why?
|
Huntington Disease | 1 | 2019 | 1147 | 0.410 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2023 | 50 | 0.410 |
Why?
|
Optic Neuropathy, Ischemic | 2 | 2024 | 87 | 0.400 |
Why?
|
Humans | 64 | 2024 | 768298 | 0.390 |
Why?
|
Pituitary Neoplasms | 1 | 2020 | 1325 | 0.390 |
Why?
|
Herpesvirus 3, Human | 2 | 2023 | 159 | 0.390 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2171 | 0.380 |
Why?
|
Ophthalmology | 1 | 2018 | 560 | 0.370 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1664 | 0.370 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4570 | 0.350 |
Why?
|
Adenoma | 1 | 2021 | 2163 | 0.350 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1428 | 0.340 |
Why?
|
Diplopia | 2 | 2021 | 217 | 0.320 |
Why?
|
Visual Field Tests | 2 | 2022 | 415 | 0.320 |
Why?
|
Eye | 2 | 2024 | 713 | 0.310 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 13019 | 0.310 |
Why?
|
Brain | 7 | 2021 | 27452 | 0.310 |
Why?
|
Tomography, Optical Coherence | 2 | 2020 | 2957 | 0.300 |
Why?
|
Recurrence | 4 | 2023 | 8501 | 0.270 |
Why?
|
Fluorescein Angiography | 2 | 2023 | 1086 | 0.260 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1937 | 0.260 |
Why?
|
Parkinson Disease | 1 | 2019 | 2893 | 0.250 |
Why?
|
Health Planning Guidelines | 1 | 2006 | 153 | 0.240 |
Why?
|
Adrenal Cortex Hormones | 3 | 2022 | 1890 | 0.230 |
Why?
|
Hyperesthesia | 1 | 2024 | 23 | 0.230 |
Why?
|
Central Nervous System | 2 | 2022 | 1346 | 0.230 |
Why?
|
Eye Pain | 2 | 2021 | 46 | 0.220 |
Why?
|
Cranial Nerves | 1 | 2024 | 98 | 0.220 |
Why?
|
Neoplasms | 2 | 2024 | 22389 | 0.220 |
Why?
|
Parvovirinae | 1 | 2022 | 10 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 155 | 0.210 |
Why?
|
Health Priorities | 1 | 2006 | 380 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 442 | 0.200 |
Why?
|
Female | 24 | 2024 | 397050 | 0.190 |
Why?
|
Meningitis, Cryptococcal | 1 | 2022 | 66 | 0.190 |
Why?
|
Hippocratic Oath | 1 | 2021 | 16 | 0.190 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 294 | 0.190 |
Why?
|
Edema | 2 | 2022 | 766 | 0.180 |
Why?
|
Waiting Lists | 1 | 2006 | 780 | 0.180 |
Why?
|
Mental Disorders | 1 | 2021 | 6876 | 0.180 |
Why?
|
Precipitating Factors | 1 | 2020 | 51 | 0.180 |
Why?
|
Sex Reassignment Procedures | 1 | 2021 | 72 | 0.180 |
Why?
|
Steroids | 2 | 2022 | 936 | 0.180 |
Why?
|
Moral Obligations | 1 | 2021 | 91 | 0.170 |
Why?
|
Mobility Limitation | 1 | 2024 | 409 | 0.170 |
Why?
|
Peroxidase | 1 | 2023 | 609 | 0.170 |
Why?
|
Meninges | 1 | 2021 | 197 | 0.160 |
Why?
|
Doxycycline | 1 | 2021 | 347 | 0.160 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.160 |
Why?
|
Adrenalectomy | 1 | 2021 | 348 | 0.160 |
Why?
|
Intracranial Hypertension | 1 | 2021 | 193 | 0.160 |
Why?
|
Retrospective Studies | 11 | 2024 | 81768 | 0.160 |
Why?
|
Fundus Oculi | 1 | 2020 | 560 | 0.150 |
Why?
|
Administration, Topical | 1 | 2020 | 703 | 0.150 |
Why?
|
Social Responsibility | 1 | 2021 | 384 | 0.150 |
Why?
|
Cerebellar Ataxia | 1 | 2019 | 151 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9742 | 0.150 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 671 | 0.150 |
Why?
|
Fertilization in Vitro | 1 | 2006 | 1302 | 0.150 |
Why?
|
Headache | 2 | 2022 | 1262 | 0.140 |
Why?
|
Plasma Cells | 1 | 2021 | 599 | 0.140 |
Why?
|
Muscle Weakness | 1 | 2020 | 415 | 0.140 |
Why?
|
Inflammation | 6 | 2023 | 10863 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 960 | 0.140 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.130 |
Why?
|
Sensation Disorders | 1 | 2017 | 160 | 0.130 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2018 | 251 | 0.130 |
Why?
|
Eye Movements | 1 | 2019 | 514 | 0.130 |
Why?
|
Adult | 12 | 2024 | 223622 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 3811 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2022 | 1476 | 0.130 |
Why?
|
Accidental Falls | 1 | 2024 | 1080 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2018 | 15854 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2020 | 975 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2020 | 534 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1837 | 0.120 |
Why?
|
Frontal Lobe | 1 | 2021 | 1428 | 0.120 |
Why?
|
China | 1 | 2020 | 2389 | 0.110 |
Why?
|
Young Adult | 6 | 2023 | 60048 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4120 | 0.100 |
Why?
|
Male | 15 | 2024 | 364870 | 0.100 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6084 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3631 | 0.100 |
Why?
|
Decompression, Surgical | 1 | 2018 | 610 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 930 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1077 | 0.100 |
Why?
|
Biopsy | 2 | 2021 | 6808 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3108 | 0.100 |
Why?
|
Immunosuppressive Agents | 2 | 2023 | 4209 | 0.090 |
Why?
|
Visual Acuity | 2 | 2018 | 2714 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1643 | 0.090 |
Why?
|
Middle Aged | 10 | 2024 | 223463 | 0.080 |
Why?
|
Aged | 8 | 2024 | 171544 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7242 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12239 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2142 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4273 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2820 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20766 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2018 | 5898 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7211 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2021 | 3909 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5802 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2097 | 0.070 |
Why?
|
Cognition | 1 | 2024 | 7074 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4740 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3279 | 0.060 |
Why?
|
Incidence | 2 | 2024 | 21544 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7453 | 0.060 |
Why?
|
Electroencephalography | 1 | 2019 | 6317 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7458 | 0.050 |
Why?
|
Knee | 1 | 2024 | 279 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6670 | 0.050 |
Why?
|
Touch | 1 | 2024 | 316 | 0.050 |
Why?
|
Meningoencephalitis | 1 | 2021 | 83 | 0.050 |
Why?
|
Family Characteristics | 1 | 2006 | 1003 | 0.040 |
Why?
|
Internship and Residency | 1 | 2021 | 5948 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 30230 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.040 |
Why?
|
Foot | 1 | 2024 | 577 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30020 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3776 | 0.040 |
Why?
|
Orbit | 1 | 2022 | 459 | 0.040 |
Why?
|
Hand | 1 | 2024 | 912 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 545 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 871 | 0.040 |
Why?
|
Genitalia | 1 | 2017 | 113 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 523 | 0.030 |
Why?
|
Pain | 2 | 2022 | 5102 | 0.030 |
Why?
|
Gait | 1 | 2021 | 822 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2021 | 785 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 993 | 0.030 |
Why?
|
Risk Factors | 2 | 2024 | 74954 | 0.030 |
Why?
|
Memory Disorders | 1 | 2021 | 1203 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2020 | 1322 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2740 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2022 | 3411 | 0.030 |
Why?
|
Piperidines | 1 | 2021 | 1660 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2529 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 2653 | 0.020 |
Why?
|
Animals | 1 | 2020 | 169322 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14783 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 65365 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10087 | 0.010 |
Why?
|
Schizophrenia | 1 | 2020 | 6987 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8615 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59683 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2015 | 5126 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41791 | 0.010 |
Why?
|
Child | 1 | 2006 | 80894 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54921 | 0.010 |
Why?
|
United States | 1 | 2021 | 73144 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89182 | 0.010 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_